The Role of Endoplasmic Reticulum Aminopeptidase 1 Biology in Immune Evasion by Tumours
Open Access
- 21 September 2015
- journal article
- Published by Peertechz Publications Private Limited in Journal of Vaccines and Immunology
- Vol. 1 (1), 028-035
- https://doi.org/10.17352/jvi.000007
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Clinical implication of HLA class I expression in breast cancerBMC Cancer, 2011
- Human cytomegalovirus microRNA miR-US4-1 inhibits CD8+ T cell responses by targeting the aminopeptidase ERAP1Nature Immunology, 2011
- Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimmingProceedings of the National Academy of Sciences of the United States of America, 2011
- Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1Nature Structural & Molecular Biology, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variantsNature Genetics, 2007
- Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinomaCancer Immunology, Immunotherapy, 2007
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007
- ERAAP Synergizes with MHC Class I Molecules to Make the Final Cut in the Antigenic Peptide Precursors in the Endoplasmic ReticulumImmunity, 2006
- Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptidesin vivoand plays an important role in immunodominanceProceedings of the National Academy of Sciences of the United States of America, 2006